Prognostic significance of dna measurements in 409 consecutive breast cancer patients

Cancer

Volumn 62, Issue 2, 1988, Pages 331-341

  Fallenius, Anders G ^a   Auer, Gert U ^a   Carstensen, John M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ASPIRATION CYTOLOGY; BREAST CANCER; CYTOCHEMISTRY; CYTOLOGY; DNA CONTENT; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PROGNOSIS;

ADULT; AGED; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; HUMAN; MIDDLE AGE; NEOPLASM RECURRENCE, LOCAL; PLOIDIES; PROGNOSIS; RETROSPECTIVE STUDIES; SPECTROPHOTOMETRY; SUPPORT, NON-U.S. GOV'T;

EID: 0023941971     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19880715)62:2<331::AID-CNCR2820620218>3.0.CO;2-8     Document Type: Article

References (51)

1. Impact of tumor grade and host resistance on survival of women with breast cancer
2. Analysis of reproducibility of subjective grading systems for breast carcinoma
3. Histopathological systems of breast cancer classification: Reproducibility and clinical significance
4. Modal deoxyribonucleic acid value and survival in carcinoma of the breast
5. Prognostic significance of modal DNA value and other factors in malignant tumors, based on 1465 cases
6. DNA content and survival in mammary carcinoma
7. Prognostic value of nuclear DNA content in papillary thyroid carcinoma
8. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival
9. Prognostic significance of nuclear DNA content in serious ovarian tumors
10. Prognostic significance of nuclear DNA analysis in histological sections in mammary carcinoma
11. Flow‐cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations
12. Influence of cellular NDA content on disease‐free survival of stage II breast cancer patients
13. The prognostic significance of nuclear DNA content in chondrosarcoma
14. Impulszytophotometrie und Katamnese beim Mammakarzinom
15. The prognostic significance of DNA measurements in endometrial carcinoma
16. Tumor ploidy and prognosis in carcinomas of the bladder and prostate
17. DNA ploidy and survival in breast cancer patients
18. Clinical DNA flow cytometry
19. DNA distribution in human colon carcinomas and its relationship to clinical behavior
20. Prognostic significance of nuclear DNA levels in prostatic carcinoma
21. Tumour aneuploidy, prognostic parameters and survival in primary breast cancer
22. DNA distribution, cytosol estrogen receptors and axillary nodes as prognostic predictors in breast carcinoma
23. The Stockholm breast cancer trial: Preliminary report of a randomized study concerning the value of preoperative or postoperative radiotherapy in operable disease
24. Adjuvant radiotherapy in operable breast cancer: Correlation between dose in internal mammary nodes and prognosis
25. Quantitative cytochemical aspects of a combined Feulgen naphtol yellow S staining procedure for the simultaneous determination of nuclear and cytoplasmic proteins and DNA in mammalian cells
26. The relationship between the nuclear DNA content in smears of aspirates and the prognosis of mucoepidermoid carcinoma
27. Cytochemical instrumentation for pathological work
28. Cytochemical changes in the nucleus during tumor development
29. Flow cytometric DNA pattern in relation to clinical and histopathological characteristics
30. Polyploidy in human tumors
31. DNA in human tumors: A cytophotometric study
32. DNA and cell cycle
33. Flow cytometry in clinical cancer research
34. Relationship of steroid receptor cell kinetics and clinical status in patients with breast cancer
35. Ploidy, proliferative activity and estrogen receptor content in human breast cancer
36. Cytophotometric measurements of the DNA‐content of human malignant tumors by means of the Feulgen‐reaction
37. Correlation between cytometric features and mitotic frequency in human breast carcinoma
38. Design and analysis of randomized clinical trials requiring prolonged observations of each patient. II. Analysis and examples
39. Regression models and life tables
40. Image and flow cytometric analysis of DNA content in breast cancer. Relation to estrogen receptor content and lymph node involvement
41. Proliferative index, cytosol estrogen receptor and axillary node status as prognostic predictors in human mammary carcinoma
42. Correlation of cell‐cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer
43. The clonal evolution of tumor cell populations
44. Tumor progression and clonal evolution: the role of genetic instability
45. Genomic rearrangement and the origin of cancer
46. On the diagnosis and treatment of breast cancer
47. Therapeutic implications from a mathematical model characterizing the course of breast cancer
48. Analysis of prognostic factors in patients with primary breast carcinoma